Syndax Pharmaceuticals依据纳斯达克上市规则5635(c)(4)披露激励性股权授予

投资观察
Jul 07

7月1日,生物制药公司Syndax Pharmaceuticals宣布,已根据纳斯达克上市规则第5635(c)(4)条的规定,向新入职员工授予了激励性股权。此类授予通常旨在吸引和留住关键人才,符合相关市场规则对新兴成长型公司的要求。公司未在本次简要披露中说明授予的具体条款或规模。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10